| Value | ₹24.00 Cr |
|---|
NSE filing, NSE: ROSSARI. Summary written from the filing by ALFA Finder's alert engine.
Rossari Biotech Ltd: key numbers
- Share price
- ₹409.45
- Market cap
- ₹2,268 Cr
- Revenue (annual)
- ₹2,396 Cr
- Net profit (annual)
- ₹149.2 Cr
- P/E (TTM)
- 14.8×Sector 33.6×
- Promoter holding
- 68.14%+0.00% QoQ
- FII holding
- 1.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rossari Biotech Ltd
All →Rossari Biotech Earnings Call Transcript: Key Takeaways
Rossari Biotech achieved record quarterly revenue and EBITDA despite volatile raw material costs and logistical headwinds.
- Call
- Guides 15% growth
Rossari Biotech Results Update
Rossari Biotech reported Q2 FY27 revenue of Rs. 697.6 crore, up 19% YoY. The company also announced plans for a new manufacturing facility in Saudi Arabia.
Rossari Biotech Investor Presentation: Key Takeaways
Rossari Biotech reported record quarterly revenue of Rs. 697.6 Cr (up 19% YoY) and EBITDA of Rs. 87 Cr (up 21% YoY). Performance driven by volume and product mix.
Rossari Biotech Q2 FY27 Results: Net Profit ₹38.9 Cr, Up 5.4% YoY
Rossari Biotech Ltd reported revenue from operations of ₹697.6 Cr (+19.0% YoY) and net profit of ₹38.9 Cr (+5.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹38.9 Cr · +5.4% YoY
Rossari Biotech Other Announcement
Rossari Biotech submitted its quarterly shareholding pattern for the period ended September 30, 2026. The filing includes minor reporting adjustments for two promoter group members.
Rossari Biotech Board Meeting Date
Rossari Biotech will hold a board meeting on October 17, 2026, to consider and approve its unaudited financial results for the quarter ending September 30, 2026.
Other merger & restructuring announcements
All →Ceigall India Merger & Restructuring Worth ₹86.32 Cr
Ceigall India Ltd will infuse Rs. 86.32 Crore into its step-down subsidiary, Ceigall Ambala Chandigarh Zirakpur Limited. The investment supports a 6-lane spur connectivity highway project in Punjab.
- Value
- ₹86.32 Cr
- highway length
- 10.3 Km
Computer Age Management Services Merger & Restructuring
CAMS disclosed the voluntary liquidation and dissolution of its non-material step-down subsidiary Think Analytics under IBC Section 59. The closure has no impact on company operations.
India Glycols Merger & Restructuring
India Glycols disclosed that IGL Spirits received BSE and NSE listing approval for 6.70 crore demerger shares. Trading in these equity shares begins on 4 November 2026.
Kaynes Technology India Merger & Restructuring Worth ₹0.25 Cr
Kaynes Technology will incorporate Kaynes Arabia Electronics Company in Saudi Arabia, holding 100% for electronics manufacturing for GCC markets. Cash consideration is Rs. 0.25 Crore, funded through multiple tranches.
- Value
- ₹0.25 Cr
RPSG Ventures Merger & Restructuring
RPSG Ventures' step-down subsidiary RPSG Brands Mena incorporated RPSG Foods & Health Products Trading FZE in Dubai's Jebel Ali Free Zone. The new entity has AED 50,000 share capital and is yet to commence business.
Rajasthan Securities Merger & Restructuring Worth ₹1 Cr
Rajasthan Securities' board approved incorporating a wholly owned subsidiary in India. Initial cash subscription of up to Rs 1 Crore is planned.
- Value
- ₹1.00 Cr